false Q1 6-K --12-31 2025-03-31 2025 DRAGANFLY INC. 0001786286 0001786286 2025-01-01 2025-03-31 0001786286 2025-03-31 0001786286 2024-12-31 0001786286 2024-01-01 2024-03-31 0001786286 ifrs-full:IssuedCapitalMember 2023-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-12-31 0001786286 ifrs-full:WarrantReserveMember 2023-12-31 0001786286 ifrs-full:RetainedEarningsMember 2023-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2023-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-12-31 0001786286 2023-12-31 0001786286 ifrs-full:IssuedCapitalMember 2024-03-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2024-03-31 0001786286 ifrs-full:WarrantReserveMember 2024-03-31 0001786286 ifrs-full:RetainedEarningsMember 2024-03-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2024-03-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2024-03-31 0001786286 2024-03-31 0001786286 ifrs-full:IssuedCapitalMember 2024-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2024-12-31 0001786286 ifrs-full:WarrantReserveMember 2024-12-31 0001786286 ifrs-full:RetainedEarningsMember 2024-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2024-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2024-12-31 0001786286 ifrs-full:IssuedCapitalMember 2024-01-01 2024-03-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2024-01-01 2024-03-31 0001786286 ifrs-full:WarrantReserveMember 2024-01-01 2024-03-31 0001786286 ifrs-full:RetainedEarningsMember 2024-01-01 2024-03-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2024-01-01 2024-03-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2024-01-01 2024-03-31 0001786286 ifrs-full:IssuedCapitalMember 2024-04-01 2024-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2024-04-01 2024-12-31 0001786286 ifrs-full:WarrantReserveMember 2024-04-01 2024-12-31 0001786286 ifrs-full:RetainedEarningsMember 2024-04-01 2024-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2024-04-01 2024-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2024-04-01 2024-12-31 0001786286 2024-04-01 2024-12-31 0001786286 ifrs-full:IssuedCapitalMember 2025-01-01 2025-03-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2025-01-01 2025-03-31 0001786286 ifrs-full:WarrantReserveMember 2025-01-01 2025-03-31 0001786286 ifrs-full:RetainedEarningsMember 2025-01-01 2025-03-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2025-01-01 2025-03-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2025-01-01 2025-03-31 0001786286 ifrs-full:IssuedCapitalMember 2025-03-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2025-03-31 0001786286 ifrs-full:WarrantReserveMember 2025-03-31 0001786286 ifrs-full:RetainedEarningsMember 2025-03-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2025-03-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2025-03-31 0001786286 DPRO:DragonflyInnovationsIncMember 2025-01-01 2025-03-31 0001786286 DPRO:DragonflyInnovationsUSAIncMember 2025-01-01 2025-03-31 0001786286 DPRO:DronelogicsSystemsIncMember 2025-01-01 2025-03-31 0001786286 2024-01-01 2024-12-31 0001786286 DPRO:InventoryMember 2025-01-01 2025-03-31 0001786286 DPRO:InventoryMember 2024-01-01 2024-03-31 0001786286 DPRO:PublicCompanySharesMember 2025-03-31 0001786286 ifrs-full:ComputerEquipmentMember 2023-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2023-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2023-12-31 0001786286 ifrs-full:VehiclesMember 2023-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2024-01-01 2024-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2024-01-01 2024-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2024-01-01 2024-12-31 0001786286 ifrs-full:VehiclesMember 2024-01-01 2024-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2024-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2024-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2024-12-31 0001786286 ifrs-full:VehiclesMember 2024-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2025-01-01 2025-03-31 0001786286 DPRO:FurnitureAndEquipmentMember 2025-01-01 2025-03-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2025-01-01 2025-03-31 0001786286 ifrs-full:VehiclesMember 2025-01-01 2025-03-31 0001786286 ifrs-full:ComputerEquipmentMember 2025-03-31 0001786286 DPRO:FurnitureAndEquipmentMember 2025-03-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2025-03-31 0001786286 ifrs-full:VehiclesMember 2025-03-31 0001786286 ifrs-full:BuildingsMember 2023-12-31 0001786286 ifrs-full:LandMember 2023-12-31 0001786286 ifrs-full:BuildingsMember 2024-01-01 2024-12-31 0001786286 ifrs-full:LandMember 2024-01-01 2024-12-31 0001786286 ifrs-full:BuildingsMember 2024-12-31 0001786286 ifrs-full:LandMember 2024-12-31 0001786286 ifrs-full:BuildingsMember 2025-01-01 2025-03-31 0001786286 ifrs-full:LandMember 2025-01-01 2025-03-31 0001786286 ifrs-full:BuildingsMember 2025-03-31 0001786286 ifrs-full:LandMember 2025-03-31 0001786286 ifrs-full:BuildingsMember 2025-03-31 0001786286 ifrs-full:BuildingsMember 2024-12-31 0001786286 ifrs-full:BottomOfRangeMember 2025-03-31 0001786286 ifrs-full:TopOfRangeMember 2025-03-31 0001786286 ifrs-full:NotLaterThanOneYearMember 2025-03-31 0001786286 ifrs-full:NotLaterThanOneYearMember 2024-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember 2025-03-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember 2024-12-31 0001786286 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember 2025-03-31 0001786286 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember 2024-12-31 0001786286 DPRO:RestrictedStockUnitsMember 2025-01-01 2025-03-31 0001786286 DPRO:RestrictedStockUnitsMember 2024-01-01 2024-12-31 0001786286 DPRO:CommonStock1Member 2024-01-01 2024-12-31 0001786286 DPRO:CommonStock1Member 2024-02-26 0001786286 ifrs-full:OrdinarySharesMember 2024-02-26 0001786286 2024-02-26 2024-02-26 0001786286 ifrs-full:OrdinarySharesMember 2024-02-26 2024-02-26 0001786286 ifrs-full:WarrantsMember 2024-02-26 2024-02-26 0001786286 DPRO:PrefundedWarrantsMember 2024-02-26 2024-02-26 0001786286 DPRO:PrefundedWarrantsMember 2024-03-27 0001786286 DPRO:PrefundedWarrantsMember 2024-03-26 0001786286 DPRO:PrefundedWarrantsMember 2025-03-31 0001786286 ifrs-full:IssuedCapitalMember 2024-01-01 2024-12-31 0001786286 DPRO:CommonStock1Member 2024-04-29 0001786286 ifrs-full:OrdinarySharesMember 2024-04-29 0001786286 2024-04-29 2024-04-29 0001786286 ifrs-full:OrdinarySharesMember 2024-04-29 2024-04-29 0001786286 ifrs-full:WarrantsMember 2024-04-29 2024-04-29 0001786286 DPRO:PrefundedWarrantsMember 2024-04-29 2024-04-29 0001786286 DPRO:CommonStock1Member 2024-08-21 0001786286 ifrs-full:OrdinarySharesMember 2024-08-21 0001786286 2024-08-21 2024-08-21 0001786286 ifrs-full:OrdinarySharesMember 2024-08-21 2024-08-21 0001786286 ifrs-full:WarrantsMember 2024-08-21 2024-08-21 0001786286 DPRO:PrefundedWarrantsMember 2024-08-21 2024-08-21 0001786286 DPRO:CommonStock1Member 2024-11-19 0001786286 ifrs-full:OrdinarySharesMember 2024-11-19 0001786286 2024-11-19 2024-11-19 0001786286 ifrs-full:OrdinarySharesMember 2024-11-19 2024-11-19 0001786286 ifrs-full:WarrantsMember 2024-11-19 2024-11-19 0001786286 DPRO:PrefundedWarrantsMember 2024-11-19 2024-11-19 0001786286 DPRO:StockOptionsMember 2025-01-01 2025-03-31 0001786286 DPRO:StockOptionsMember 2024-01-01 2024-03-31 0001786286 DPRO:RestrictedStockUnitsMember 2024-01-01 2024-03-31 0001786286 2024-08-07 2024-08-07 0001786286 DPRO:OctoberWarrantsMember 2024-08-07 0001786286 DPRO:ExercisePriceOneMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-03-31 0001786286 DPRO:ExercisePriceOneMember DPRO:IncentiveShareCompensationPlanMember 2025-03-31 0001786286 DPRO:ExercisePriceTwoMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-03-31 0001786286 DPRO:ExercisePriceTwoMember DPRO:IncentiveShareCompensationPlanMember 2025-03-31 0001786286 DPRO:ExercisePriceThreeMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-03-31 0001786286 DPRO:ExercisePriceThreeMember DPRO:IncentiveShareCompensationPlanMember 2025-03-31 0001786286 DPRO:ExercisePriceFourMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-03-31 0001786286 DPRO:ExercisePriceFourMember DPRO:IncentiveShareCompensationPlanMember 2025-03-31 0001786286 DPRO:ExercisePriceFiveMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-03-31 0001786286 DPRO:ExercisePriceFiveMember DPRO:IncentiveShareCompensationPlanMember 2025-03-31 0001786286 DPRO:ExercisePriceSixMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-03-31 0001786286 DPRO:ExercisePriceSixMember DPRO:IncentiveShareCompensationPlanMember 2025-03-31 0001786286 DPRO:ExercisePriceSevenMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-03-31 0001786286 DPRO:ExercisePriceSevenMember DPRO:IncentiveShareCompensationPlanMember 2025-03-31 0001786286 DPRO:ExercisePriceEightMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-03-31 0001786286 DPRO:ExercisePriceEightMember DPRO:IncentiveShareCompensationPlanMember 2025-03-31 0001786286 DPRO:ExercisePriceNineMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-03-31 0001786286 DPRO:ExercisePriceNineMember DPRO:IncentiveShareCompensationPlanMember 2025-03-31 0001786286 DPRO:ExercisePriceTenMember DPRO:IncentiveShareCompensationPlanMember 2025-01-01 2025-03-31 0001786286 DPRO:ExercisePriceTenMember DPRO:IncentiveShareCompensationPlanMember 2025-03-31 0001786286 DPRO:IncentiveShareCompensationPlanMember 2025-03-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2023-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2024-01-01 2024-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2024-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2025-01-01 2025-03-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2025-03-31 0001786286 ifrs-full:WarrantsMember DPRO:FebruaryIssuanceMember 2025-01-01 2025-03-31 0001786286 DPRO:BrokerMember DPRO:FebruaryIssuanceMember 2025-01-01 2025-03-31 0001786286 ifrs-full:WarrantsMember DPRO:AprilIssuanceMember 2025-01-01 2025-03-31 0001786286 DPRO:BrokerMember DPRO:AprilIssuanceMember 2025-01-01 2025-03-31 0001786286 DPRO:BrokerMember DPRO:AugustIssuanceMember 2025-01-01 2025-03-31 0001786286 DPRO:BrokerMember DPRO:NovemberIssuanceMember 2025-01-01 2025-03-31 0001786286 ifrs-full:WarrantsMember 2023-12-31 0001786286 ifrs-full:WarrantsMember 2024-01-01 2024-12-31 0001786286 ifrs-full:WarrantsMember 2024-12-31 0001786286 ifrs-full:WarrantsMember 2025-01-01 2025-03-31 0001786286 ifrs-full:WarrantsMember 2025-03-31 0001786286 DPRO:RangeOneMember 2025-01-01 2025-03-31 0001786286 DPRO:RangeOneMember 2025-03-31 0001786286 DPRO:RangeOneMember 2024-12-31 0001786286 ifrs-full:WarrantReserveMember DPRO:RangeOneMember 2025-03-31 0001786286 ifrs-full:WarrantReserveMember DPRO:RangeOneMember 2024-12-31 0001786286 ifrs-full:WarrantReserveMember DPRO:RangesTwoMember 2025-03-31 0001786286 ifrs-full:WarrantReserveMember DPRO:RangesTwoMember 2024-12-31 0001786286 ifrs-full:WarrantReserveMember DPRO:RangeThreeMember 2025-03-31 0001786286 ifrs-full:WarrantReserveMember DPRO:RangeThreeMember 2024-12-31 0001786286 ifrs-full:WarrantReserveMember DPRO:RangeFourMember 2025-03-31 0001786286 ifrs-full:WarrantReserveMember DPRO:RangeFourMember 2024-12-31 0001786286 ifrs-full:WarrantReserveMember 2025-03-31 0001786286 ifrs-full:WarrantReserveMember 2024-12-31 0001786286 ifrs-full:WarrantsMember 2025-01-01 2025-03-31 0001786286 ifrs-full:WarrantsMember 2024-01-01 2024-12-31 0001786286 ifrs-full:WarrantsMember 2023-12-31 0001786286 ifrs-full:WarrantsMember 2024-12-31 0001786286 ifrs-full:WarrantsMember 2025-03-31 0001786286 DPRO:WarrantOneMember 2025-01-01 2025-03-31 0001786286 DPRO:WarrantOneMember 2025-03-31 0001786286 DPRO:WarrantTwoMember 2025-01-01 2025-03-31 0001786286 DPRO:WarrantTwoMember 2025-03-31 0001786286 DPRO:WarrantThreeMember 2025-01-01 2025-03-31 0001786286 DPRO:WarrantThreeMember 2025-03-31 0001786286 DPRO:WarrantFourMember 2025-01-01 2025-03-31 0001786286 DPRO:WarrantFourMember 2025-03-31 0001786286 DPRO:WarrantFiveMember 2025-01-01 2025-03-31 0001786286 DPRO:WarrantFiveMember 2025-03-31 0001786286 DPRO:WarrantSixMember 2025-01-01 2025-03-31 0001786286 DPRO:WarrantSixMember 2025-03-31 0001786286 DPRO:WarrantSevenMember 2025-01-01 2025-03-31 0001786286 DPRO:WarrantSevenMember 2025-03-31 0001786286 DPRO:WarrantEightMember 2025-01-01 2025-03-31 0001786286 DPRO:WarrantEightMember 2025-03-31 0001786286 DPRO:WarrantNineMember 2025-01-01 2025-03-31 0001786286 DPRO:WarrantNineMember 2025-03-31 0001786286 DPRO:WarrantTenMember 2025-01-01 2025-03-31 0001786286 DPRO:WarrantTenMember 2025-03-31 0001786286 DPRO:DronesMember 2025-01-01 2025-03-31 0001786286 DPRO:CorporatesMember 2025-01-01 2025-03-31 0001786286 DPRO:DronesMember 2024-01-01 2024-03-31 0001786286 DPRO:CorporatesMember 2024-01-01 2024-03-31 0001786286 DPRO:CAMember 2025-03-31 0001786286 DPRO:CAMember 2024-12-31 0001786286 DPRO:CAMember 2025-01-01 2025-03-31 0001786286 DPRO:CAMember 2024-01-01 2024-03-31 0001786286 DPRO:USCountryMember 2025-01-01 2025-03-31 0001786286 DPRO:USCountryMember 2024-01-01 2024-03-31 0001786286 DPRO:BusinessInstinctsGroupMember DPRO:BusinessServicesAgreementMember 2025-01-01 2025-03-31 0001786286 DPRO:BusinessInstinctsGroupMember DPRO:BusinessServicesAgreementMember 2024-01-01 2024-03-31 0001786286 DPRO:BusinessInstinctsGroupMember DPRO:BusinessServicesAgreementMember 2025-03-31 0001786286 DPRO:BusinessInstinctsGroupMember DPRO:BusinessServicesAgreementMember 2024-03-31 0001786286 DPRO:AlbertaLtdMember DPRO:IndependentConsultantAgreementMember 2025-01-01 2025-03-31 0001786286 DPRO:AlbertaLtdMember DPRO:IndependentConsultantAgreementMember 2024-01-01 2024-03-31 0001786286 DPRO:AlbertaLtdMember DPRO:IndependentConsultantAgreementMember 2025-03-31 0001786286 DPRO:AlbertaLtdMember DPRO:IndependentConsultantAgreementMember 2024-03-31 0001786286 DPRO:ScottLarsonMember DPRO:ExecutiveAgreementMember 2025-01-01 2025-03-31 0001786286 DPRO:ScottLarsonMember DPRO:ExecutiveAgreementMember 2024-01-01 2024-03-31 0001786286 DPRO:ScottLarsonMember DPRO:ExecutiveAgreementMember 2025-03-31 0001786286 DPRO:ScottLarsonMember DPRO:ExecutiveAgreementMember 2024-03-31 0001786286 DPRO:CEOAndDirectorMember 2025-01-01 2025-03-31 0001786286 DPRO:CEOAndDirectorMember 2024-01-01 2024-03-31 0001786286 DPRO:CEOMember 2025-01-01 2025-03-31 0001786286 DPRO:CEOMember 2024-01-01 2024-03-31 0001786286 DPRO:DirectorsMember 2025-01-01 2025-03-31 0001786286 DPRO:DirectorsMember 2024-01-01 2024-03-31 0001786286 ifrs-full:OtherRelatedPartiesMember 2025-01-01 2025-03-31 0001786286 ifrs-full:OtherRelatedPartiesMember 2024-01-01 2024-03-31 0001786286 ifrs-full:Level1OfFairValueHierarchyMember 2025-03-31 0001786286 ifrs-full:Level3OfFairValueHierarchyMember 2025-03-31 0001786286 ifrs-full:Level1OfFairValueHierarchyMember 2024-12-31 0001786286 ifrs-full:Level3OfFairValueHierarchyMember 2024-12-31 0001786286 ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember 2025-01-01 2025-03-31 0001786286 ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember 2024-01-01 2024-12-31 0001786286 DPRO:SingleInstitutionalInvestorMember DPRO:NonadjustingEventsMember 2025-05-05 0001786286 DPRO:SingleInstitutionalInvestorMember DPRO:NonadjustingEventsMember 2025-05-05 2025-05-05 0001786286 DPRO:NonadjustingEventsMember 2025-05-05 2025-05-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares iso4217:CAD xbrli:shares iso4217:CAD xbrli:pure DPRO:Segments

 

Exhibit 99.1

 

 

Draganfly Inc.

 

Condensed Consolidated Interim Financial Statements - Unaudited

 

For the Three Months Ended March 31, 2025

 

(Expressed in Canadian Dollars)

 

 

 

 

Draganfly Inc.

Condensed Consolidated Interim Statements of Financial Position - Unaudited

Expressed in Canadian Dollars

 

 

As at  Notes  March 31, 2025   December 31, 2024 
            
ASSETS             
Current Assets             
Cash and cash equivalents     $2,126,103   $6,252,409 
Receivables  4   577,669    573,390 
Inventory  5   1,968,547    1,532,263 
Prepaids and Deposits  6   1,179,306    724,513 
Total current assets      5,851,625    9,082,575 
              
Equipment  8   510,267    529,542 
Intangible assets      42,884    45,141 
Investments  7   21,459    14,286 
Receivables  4   156,200    156,200 
Right of use assets  9   336,662    372,344 
TOTAL ASSETS     $6,919,097   $10,200,088 
              
LIABILITIES AND SHAREHOLDERS’ EQUITY             
Current Liabilities             
Trade payables and accrued liabilities  11,17  $2,484,349   $2,399,187 
Customer deposits      426,527    466,295 
Deferred income  12   37,221    18,542 
Derivative liability  13   2,040,291    2,198,121 
Lease liabilities  10   157,994    154,147 
Total current liabilities      5,146,382    5,236,292 
              
Non-current Liabilities             
Deferred Income  12   63,164    68,139 
Lease liabilities  10   232,903    273,874 
TOTAL LIABILITIES      5,442,449    5,578,305 
              
SHAREHOLDERS’ EQUITY             
Share capital  13   111,222,778    110,742,984 
Reserves - share-based payments  13   7,507,087    7,698,304 
Reserves - warrants      3,776,428    3,776,428 
Accumulated deficit      (120,890,654)   (117,465,829)
Accumulated other comprehensive income      (138,991)   (130,104)
TOTAL SHAREHOLDERS’ EQUITY      1,476,648    4,621,783 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY     $6,919,097   $10,200,088 

 

Nature and Continuance of Operations (Note 1)

Subsequent event (Note 19)

 

Approved and authorized for issuance by the Board of Directors on May 8, 2025.

 

“Scott Larson”   “Cameron Chell”  
Director   Director  

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

 

 

 

Draganfly Inc.

Condensed Consolidated Interim Statements of Comprehensive Loss - Unaudited

Expressed in Canadian Dollars

 

 

      March 31, 2025   March 31, 2024 
      For the three months ended 
      March 31, 2025   March 31, 2024 
            
Sales of goods  14  $1,541,811   $1,237,948 
Provision of services  14   5,904    91,633 
TOTAL REVENUE      1,547,715    1,329,581 
              
COST OF SALES  5   (1,237,627)   (1,049,570)
              
GROSS PROFIT      310,088    280,011 
              
OPERATING EXPENSES             
Amortization     $2,257   $2,821 
Depreciation  8,9   75,416    143,122 
Director fees  17   132,651    152,438 
Insurance      155,749    364,274 
Office and miscellaneous  15   537,689    346,270 
Professional fees      790,177    580,260 
Research and development      161,886    121,391 
Share-based payments  13,17   288,883    198,907 
Travel      125,008    40,019 
Wages and salaries  17   1,641,319    1,581,431 
Total operating expenses      (3,911,035)   (3,530,933)
OTHER INCOME             
Change in fair value of derivative liability  13   157,830    1,817,569 
Finance and other costs      34,031    4,825 
Foreign exchange gain (loss)      (17,240)   66,736 
Gain on disposal of assets      -    43,528 
Gain on recovery of notes receivable      25,951    6,751 
Other expense  16   (24,450)   (552,295)
 Total Other operating income     $176,122   $1,387,114 
              
NET LOSS     $(3,424,825)  $(1,863,808)
OTHER COMPREHENSIVE LOSS             
Items that may be reclassified to profit or loss             
Foreign exchange translation      (16,060)   (9,562)
Items that will not be reclassified to profit or loss             
Change in fair value of equity investments at FVOCI  7   7,173    (11,046)
COMPREHENSIVE LOSS      (3,433,712)   (1,884,416)
              
Net Loss per share – Basic & diluted     $(0.63)  $(0.85)
Weighted average number of common shares outstanding – Basic & diluted      5,427,795    2,197,354 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

 

 

 

Draganfly Inc.

Condensed Consolidated Interim Statements of Changes in Shareholders’ Equity - Unaudited

Expressed in Canadian Dollars

 

 

   Number of Shares  

Share Capital

  

Reserve –

Share-Based

Payments

  

 

 

Reserves –Warrants

   Accumulated Deficit  

Change

in Fair

Value of Investments at FVTOCI

  

Exchange

Differences on Translation of Foreign Operations

  

Total

Shareholders’

Equity

 
                       Accumulated Other Comprehensive Income (Loss)     
   Number of Shares  

Share Capital

  

Reserve –

Share-Based

Payments

  

 

 

Reserves –Warrants

   Accumulated Deficit  

Change

in Fair

Value of Investments at FVTOCI

  

Exchange

Differences on Translation of Foreign Operations

  

Total

Shareholders’

Equity

 
Balance at December 31, 2023   1,969,566   $97,070,976   $6,870,139   $-   $(103,588,356)  $(434,303)  $489,260   $407,716 
Shares issued for financing   448,000    2,017,966    -    -    -    -    -    2,017,966 
Share issue costs   -    (338,836)   72,185    -    -    -    -    (266,651)
Shares issued for the exercise of warrants   152,000    1,205,005    -    -    -    -    -    1,205,005 
Shares issued for the exercise of RSUs   2,547    68,751    (68,751)   -    -    -    -    - 
Share-based payments   -    -    198,907    -    -    -    -    198,907 
Shares returned to treasury   (36,000)   -    -    -    -    -    -    - 
Net loss   -    -    -    -    (1,863,808)   -    -    (1,863,808)
Change in fair value of equity investments at FVOCI   -    -    -    -    -    (11,046)   -    (11,046)
Translation of foreign operations   -    -    -    -    -    -    (9,562)   (9,562)
Balance at March 31, 2024   2,536,113   $100,023,862   $7,072,480   $-   $(105,452,164)  $(445,349)  $479,698   $1,678,527 
Shares issued for financing   1,029,208    8,366,179    -    -    -    -    -    8,366,179 
Share issue costs   -    (1,294,035)   437,269    -                   (856,766)
Shares issued for the exercise of warrant   1,839,668    2,851,822    -    -    -    -    -    2,851,822 
Shares issued for the exercise of RSUs   22,806    795,156    (795,156)   -    -    -    -    - 
Warrants – equity treatment   -    -    -    3,776,428    -    -    -    3,776,428 
Share-based payments   -    -    983,711    -    -    -    -    983,711 
Net loss   -    -    -    -    (12,013,665)   -    -    (12,013,665)
Change in fair value of equity investments at FVOCI   -    -    -    -    -    (164,071)   -    (164,071)
Translation of foreign operations   -    -    -    -    -    -    (382)   (382)
Balance at December 31, 2024   5,427,795   $110,742,984   $7,698,304   $3,776,428   $(117,465,829)  $(609,420)  $479,316   $4,621,783 
Share issue costs   -    (306)   -    -    -    -    -    (306)
Shares issued for the exercise of RSUs   6,029    480,100    (480,100)   -    -    -    -    - 
Share-based payments   -    -    288,883    -    -    -    -    288,883 
Net loss   -    -    -    -    (3,424,825)   -    -    (3,424,825)
Change in fair value of equity investments at FVOCI   -    -    -    -    -    7,173    -    7,173 
Translation of foreign operations   -    -    -    -    -    -    (16,060)   (16,060)
Balance at March 31, 2025   5,433,824   $111,222,778   $7,507,087   $3,776,428   $(120,890,654)  $(602,247)  $463,256   $

1,476,648

 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

 

 

 

Draganfly Inc.

Condensed Consolidated Interim Statements of Cash Flows - Unaudited

Expressed in Canadian Dollars

 

 

   2025   2024 
   For the three months ended 
   March 31, 2025   March 31, 2024 
         
OPERATING ACTIVITIES          
Net loss  $(3,424,825)  $(1,863,808)
Adjustments for:          
Amortization   2,257    2,821 
Depreciation   75,416    143,122 
Impairment of accounts receivable   186,440    - 
Change in fair value of derivative liability   (157,830)   (1,817,569)
Impairment (recovery) of inventory   (38,666)   148,760 
Impairment (Gain) on recovery of notes receivable   (25,951)   (6,751)
Finance and other costs   (306)   485,849 
Gain on disposal of assets   -    (43,528)
Share-based payments   288,883    198,907 
Adjustments for profit loss   (3,094,582)   (2,752,197)
Net changes in non-cash working capital items:          
Receivables   (190,719)   2,832 
Inventory   (385,650)   (11,845)
Prepaids   (454,793)   268,279 
Trade payables and accrued liabilities   85,162    (111,045)
Customer deposits   (39,768)   (42,321)
Deferred income   13,704    228 
Cash used in operating activities   (4,066,646)   (2,646,069)
           
INVESTING ACTIVITIES          
Purchase of equipment   (32,427)   (4,066)
Disposal of equipment   -    73,366 
Repayment of notes receivable   25,951    6,751 
Cash provided by (used in) investing activities   (6,476)   76,051 
           
FINANCING ACTIVITIES          
Proceeds from issuance of common shares for financing   -    4,877,475 
Share issue costs   -    (889,482)
Proceeds from issuance of common shares for warrants exercised   -    513 
Repayment of loans   -    (81,685)
Repayment of lease liabilities   (37,124)   (81,117)
Cash provided by (used in) financing activities   (37,124)   3,825,704 
           
Effects of exchange rate changes on cash   (16,060)   (9,562)
Change in cash   (4,110,246)   1,255,686 
Cash and cash equivalents, beginning of period   6,252,409    3,093,612 
Cash and cash equivalents, end of period  $2,126,103   $4,339,736 
           
SUPPLEMENTARY CASH FLOW DISCLOSURE          
Interest paid  $10,506   $21,522 
Share issue costs in accounts payable   -    153,455 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

 

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2025

Expressed in Canadian Dollars (unaudited)

 

 

 

1.NATURE AND CONTINUANCE OF OPERATIONS

 

Draganfly Inc. (the “Company”) was incorporated on June 1, 2018 under the Business Corporations Act (British Columbia). The Company creates quality, cutting-edge unmanned and remote data collection and analysis platforms and systems that are designed to revolutionize the way companies do business. The Company’s shares trade on the Canadian Securities Exchange (the “CSE”), on the Nasdaq Capital Market (the “Nasdaq”) under the symbol “DPRO” and on the Frankfurt Stock Exchange under the symbol “3U8A”. The Company’s head office is located at 235 103rd St. E, Saskatoon, SK, S7N 1Y8 and its registered office is located at 2800 – 666 Burrard Street, Vancouver, BC, V6C 2Z7.

 

These condensed consolidated interim financial statements have been prepared on the assumption that the Company will continue as a going concern, meaning it will continue in operation for the foreseeable future and will be able to realize assets and discharge liabilities in the ordinary course of operations. To date, the Company has not been profitable and has an accumulated deficit of $120,890,654. The Company’s ability to continue as a going concern is dependent upon its ability to obtain additional financing and or achieve profitable operations in the future. These factors raise substantial doubt over the Company’s ability to continue as a going concern. These condensed consolidated interim financial statements do not reflect adjustments that would be necessary if the going concern assumption were not appropriate. These adjustments could be material.

 

2.BASIS OF PREPARATION

 

Statement of Compliance

 

These condensed consolidated interim financial statements have been prepared in accordance with International Accounting Standard (“IAS”) 34, “Interim Financial Reporting”. These condensed consolidated interim financial statements include all necessary disclosures required for interim financial statements but do not include all disclosures required for annual financial statements. These condensed consolidated interim financial statements should be read in conjunction with the Company’s annual financial statements for the year ended December 31, 2024.

 

These condensed consolidated interim financial statements were authorized for issue by the Board of Directors on May 8, 2025.

 

Basis of consolidation

 

Each subsidiary is fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continues to be consolidated until the date when such control ceases.

 

The condensed consolidated interim financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table:

 

Name of Subsidiary   Place of Incorporation   Ownership Interest
Draganfly Innovations Inc. (DII)   Canada   100%
Draganfly Innovations USA, Inc. (DI USA)   US   100%
Dronelogics Systems Inc. (“Dronelogics”)   Canada   100%

 

All intercompany balances and transactions were eliminated on consolidation.

 

 

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2025

Expressed in Canadian Dollars (unaudited)

 

 

3.MATERIAL ACCOUNTING POLICY INFORMATION, ESTIMATES, AND JUDGEMENTS

 

These condensed consolidated interim financial statements have been prepared following the same accounting principles and methods of computation as in outlined in the Company’s consolidated financial statements for the year ended December 31, 2024. A description of the accounting standards and interpretations that have been adopted by the Company can be found in the notes of the annual consolidated financial statements for the year ended December 31, 2024.

 

The preparation of the condensed consolidated interim financial statements requires management to make assumptions and estimates that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of income and expenses during the reporting period. These condensed consolidated interim financial statements include estimates, which by their nature, are uncertain. These assumptions and associated estimates are based on historical experience and other factors that are considered to be relevant. As such, actual results may differ from estimates and the effect of such differences may be material. Significant estimates and judgements used in the preparation of these condensed consolidated interim financial statements remained unchanged from those disclosed in the Company’s annual consolidated financial statements for the year ended December 31, 2024.

 

4.RECEIVABLES

 

As at  March 31, 2025   December 31, 2024 
Trade accounts receivable  $667,330   $674,998 
Sales tax receivable   66,539    54,592 
Trade and other receivables, gross  $733,869   $729,590 
Current portion  $577,669   $573,390 
Long term portion   156,200    156,200 
Trade and other receivables, net  $733,869   $729,590 

 

Provision for doubtful accounts

 

Balance at December 31, 2023   289,495 
Increase during the year   140,011 
Balance at December 31, 2024   429,506 
Increase during the period   26,703 
Balance at March 31, 2025  $456,209 

 

During the three months ended March 31, 2025, the Company recorded a provision for doubtful accounts of $26,703 (2024 – $nil).

 

The long-term receivable represents a refundable deposit that the Company has asked to have returned. The agreement allows for a two-year repayment term once the request has been made. Funds were requested in April of 2024.

 

The Company applies a direct customer analysis approach to measure expected credit losses. The Company assesses collectability of receivables of each customer on an individual basis using quantitative and qualitative information available to management. The historical loss rates are adjusted to reflect the current and forward-looking information on economic factors affecting the ability of the customers to make regular monthly payments on the receivables.

 

Receivables are written off when there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include business closure and/or the failure to make monthly contractual payments.

 

 

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2025

Expressed in Canadian Dollars (unaudited)

 

 

5.INVENTORY

 

As at  March 31, 2025   December 31, 2024 
Finished goods  $1,188,887   $954,453 
Parts   779,660    577,810 
Inventories  $1,968,547   $1,532,263 

 

During the three months ended March 31, 2025, $1,071,164 (2024 - $966,339) of inventory was recognized in cost of sales including a recovery of allowance to value its inventory for obsolete and slow-moving inventory of $38,666 (2024 -allowance to value of inventory for obsolete and slow-moving inventory $148,760).

 

Cost of sales consist of the following:

 

For the three months ended  March 31, 2025   March 31, 2024 
Inventory  $1,071,164   $966,339 
Consulting and services   24,389    22,474 
Other   142,074    60,757 
Cost of sales  $1,237,627   $1,049,570 

 

6.PREPAIDS AND DEPOSITS

 

As at  March 31, 2025   December 31, 2024 
Insurance  $222,601   $370,609 
Prepaid other   184,244    112,439 
Deposits   772,461    241,465 
Prepaid expenses and deposits   $1,179,306   $724,513 

 

7.INVESTMENTS

 

Balance at December 31, 2024  $14,286 
Change in fair value   7,173 
Balance at March 31, 2025  $21,459 

 

Fair value of investments is comprised of:

 

Public company shares  $21,459 
Balance at March 31, 2025  $21,459 

 

The Company holds 1,428,571 common shares (2024 – 1,428,571) and nil (2024 – nil) warrants of Windfall Geotek Inc. a publicly traded company. At March 31, 2025 the fair value of the shares was based on the quoted price of $0.015 (2024 - $0.01). As of the issue date of these condensed consolidated interim financial statements the quoted price of the shares was $0.02.

 

 

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2025

Expressed in Canadian Dollars (unaudited)

 

 

8.EQUIPMENT

 

Cost                         
   Computer Equipment   Furniture and Equipment   Leasehold Improvements   Vehicles   Total 
Cost                         
Balance at December 31, 2023  $133,273   $1,040,192   $86,530   $60,343   $1,320,338 
Additions   6,876    137,562    2,359    -    146,797 
Disposals   (9,821)   (180,338)   -    -    (190,159)
Balance at December 31, 2024   130,328    997,416    88,889    60,343    1,276,976 
Additions   9,615    22,812    -    -    32,427 
Disposals   -    -    -    -    - 
Balance at March 31, 2025  $139,943   $1,020,228   $88,889   $60,343   $1,309,403 
                          
Accumulated depreciation                         
Balance at December 31, 2023  $58,178   $545,403   $6,790   $29,166   $639,537 
Charge for the year   37,881    143,885    17,845    9,354    208,965 
Disposals   (3,383)   (97,685)   -    -    (101,068)
Balance at December 31, 2024   92,676    591,603    24,635    38,520    747,434 
Charge for the period   8,371    37,222    4,472    1,637    51,702 
Disposals   -    -    -    -    - 
Balance at March 31, 2025  $101,047   $628,825   $29,107   $40,157   $799,136 
                          
Net book value:                         
December 31, 2024  $37,652   $405,813   $64,254   $21,823   $529,542 
March 31, 2025  $38,896   $391,403   $59,782   $20,186   $510,267 

 

 

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2025

Expressed in Canadian Dollars (unaudited)

 

 

9.RIGHT OF USE ASSETS

 

The Company has three leases with expiration dates of May 31, 2026, January 31, 2027, and September 30, 2028.

 

 

    Buildings   Land   Total 
              
Balance at December 31, 2023   $515,071   $206,616   $721,687 
Depreciation    (142,727)   (214,114)   (356,841)
Foreign exchange translation    -    7,498    7,498 
Balance at December 31, 2024   $372,344   $-   $372,344 
Depreciation    (35,682)   -    (35,682)
Balance at March 31, 2025   $336,662   $-   $336,662 

 

The condensed consolidated interim statement of financial position shows the following amounts related to leases:

 

   March 31, 2025   December 31, 2024 
Buildings  $336,662   $372,344 

 

There were no additions to the right of use assets during the three months ended March 31, 2025 nor the year ended December 31, 2024.

 

 

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2025

Expressed in Canadian Dollars (unaudited)

 

 

10.LEASE LIABILITIES

 

The Company leases certain assets under lease agreements. The lease liabilities consist of leases of facilities and vehicles with terms ranging from one to five years. The leases are calculated using incremental borrowing rates ranging from 11.7% to 13.3%.

 

  Total 
Balance at December 31, 2023  $790,023 
Interest expense   65,378 
Lease payments   (423,157)
Foreign exchange translation   (4,223)
Balance at December 31, 2024   428,021 
Interest expense   10,590 
Lease payments   (47,714)
Balance at March 31, 2025  $390,897 

 

Which consists of:

 

   March 31, 2025   December 31, 2024 
Current lease liability  $157,994   $154,147 
Non-current lease liability   232,903    273,874 
Ending balance  $390,897   $428,021 

 

Maturity analysis  March 31, 2025   December 31, 2024 
Less than one year  $190,857   $190,856 
One to three years   230,092    282,419 
Four to five years   28,734    71,836 
Total undiscounted lease liabilities   449,683    545,111 
Amount representing interest   (58,786)   (117,090)
Lease liability   $390,897   $428,021 

 

Variable lease payments of $28,807, (2024 – $20,614) have been recognized in profit and loss.

 

11.TRADE PAYABLES AND ACCRUED LIABILITIES

 

As at  March 31, 2025   December 31, 2024 
Trade accounts payable  $439,814   $609,869 
Accrued liabilities   2,044,535    1,789,318 
Trade payables and accrued liabilities   $2,484,349   $2,399,187 

 

 

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2025

Expressed in Canadian Dollars (unaudited)

 

 

12.DEFERRED INCOME

 

At times, the Company may take payment in advance for services to be rendered. These amounts are held and recognized as services are rendered.

 

   March 31, 2025   December 31, 2024 
Deferred, revenue beginning  $86,681   $107,674 
Revenue recognized   (3,633)   (21,852)
Unearned revenues received   19,159    1,744 
Foreign exchange   (1,822)   (885)
Deferred income gross   $100,385   $86,681 
Current portion  $37,221   $18,542 
Long term portion   63,164    68,139 
Deferred Income net   $100,385   $86,681 

 

Deferred revenue of $37,221 as of March 31, 2025 is expected to be recognized as revenue within one year. The remaining is related to a long-term support and maintenance arrangements and will be recognized according to the terms of these arrangements over the next 2.9 years.

 

 

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2025

Expressed in Canadian Dollars (unaudited)

 

 

13.SHARE CAPITAL

 

Authorized share capital

 

Unlimited number of common shares without par value.

 

Issued share capital

 

During the three months ended March 31, 2025,

 

The Company issued 6,029 common shares for the vesting of restricted share units.

 

During the year ended December 31, 2024,

 

The Company issued 25,353 common shares for the vesting of restricted share units.
The Company issued 1,991,668 common shares for the exercise of warrants
On February 26, 2024, the Company issued 448,000 units consisting of one common share and one warrant and 88,000 units consisting of one prefunded warrant and one warrant in a financing for $4,877,475 with share issuance costs of $752,498 for net proceeds of $4,124,977. Of the total share issuance costs $441,166 was expensed in other income (expense). The value of the issuance was allocated $2,017,966 to the shares, and $2,859,509 to the warrants, including $431,084 allocated to prefunded warrants. The prefunded warrants were exercised on the date of issue. On March 27, 2024, the exercise price of the warrants was amended to US$0.1761 from the original exercise price of USD $0.36 due to a one time exercise price reset Post share consolidation, the new exercise price is US$4.4025.
36,000 shares were returned to treasury that were held in escrow related to the Vital Intelligence Inc. acquisition for failure to meet required milestones. The shares had a carrying value of $nil on cancellation.
On April 29, 2024, the Company issued 282,541 units consisting of one common share and one warrant and 258,000 units consisting of one prefunded warrant and one warrant in a financing for $4,882,168 with share issuance costs of $779,615 for net proceeds of $4,102,553. Of the total share issuance costs $671,747 was expensed in other income (expense). The value of the issuance was allocated $396,137 to the shares, and $4,422,815 to the warrants, including $1,248,343 allocated to prefunded warrants.
On August 21, 2024, the Company issued 346,667 units consisting of one common share and one warrant, and 320,000 units consisting of one prefunded warrant and one warrant in a financing for $2,720,050 with share issue costs of $343,676 for net proceeds of $2,376,374. The value of the issuance was allocated $160,076 to the shares, and $2,559,974 to the warrants including $591,265 allocated to prefunded warrants.
On November 19, 2024 the Company issued 400,000 units consisting of one common share and one warrant and 1,200,000 units consisting of one prefunded warrant and one warrant in a financing for $5,272,234 with share issue costs of $755,387 for net proceeds of $4,516,837. The value of the issuance was allocated $329,515 to the shares and $4,942,719 to the warrants including $1,977,088 allocated to the prefunded warrants.

 

Stock Options

 

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the CSE requirements, grant to directors, officers, employees, and technical consultants to the Company, non-transferable stock options to purchase common shares. The total number of common shares reserved and available for grant and issuance pursuant to this plan shall not exceed 15% (in the aggregate) of the issued and outstanding common shares from time to time. The number of options awarded and underlying vesting conditions are determined by the Board of Directors in its discretion.

 

 

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2025

Expressed in Canadian Dollars (unaudited)

 

 

13.SHARE CAPITAL (CONT’D)

 

As at March 31, 2025, the Company had the following options outstanding and exercisable:

 

Grant Date  Expiry Date  Exercise Price   Remaining Contractual Life (years)   Number of Options Outstanding   Number of Options Exercisable 
October 30, 2019  October 30, 2029   $62.50    4.57    11,130    11,130 
April 30, 2020  April 30, 2030   $62.50    5.07    320    320 
April 30, 2020  April 30, 2030   $96.25    5.07    4,400    4,400 
July 3, 2020  July 3, 2025   $80.00    0.26    4,000    4,000 
November 24, 2020  November 24, 2030   $62.50    5.64    1,280    1,280 
February 2, 2021  February 2, 2031   $330.00    5.83    1,200    1,200 
March 8, 2021  March 8, 2026   $347.50    0.93    400    400 
April 27, 2021  April 27, 2031   $253.75    6.06    4,240    4,240 
September 9, 2021  September 9, 2026   $121.00    1.44    1,034    1,034 
November 9, 2023  November 9, 2033   $15.75    8.59    1,200    800 
                 29,204    28,804 

 

   Number of Options   Weighted Average Exercise Price 
Outstanding, December 31, 2023   35,954   $112.00 
Forfeited   (4,350)   106.83 
Outstanding, December 31, 2024   31,604   $112.05 
Forfeited   -2,400    94.38 
Outstanding, March 31, 2025   29,204   $105.50 

 

No options were granted by the Company during the three months ended March 31, 2025.

 

During the three months ended March 31, 2024, the Company recorded $1,013 (2024 – $26,689) in stock-based compensation in relation to the vesting of stock options. The fair values of stock options granted were estimated using the Black-Scholes Option Pricing Model.

 

Restricted Share Units

 

During the three months ended March 31, 2025, the Company recorded share-based payment expense of $287,869 (2024 - $172,218) for RSUs, based on the fair values of RSUs granted which were calculated using the closing price of the Company’s stock on the day prior to grant.

 

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the Exchange requirements, grant to directors, officers, employees and technical consultants to the Company, restricted stock units (RSUs). The number of RSUs awarded and underlying vesting conditions are determined by the Board of Directors in its discretion. RSUs will have a 3-year vesting period following the award date. The total number of common shares reserved and available for grant and issuance pursuant to this plan, and the total number of Restricted Share Units that may be awarded pursuant to this plan, shall not exceed 15% (in the aggregate) of the issued and outstanding common shares from time to time.

 

 

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2025

Expressed in Canadian Dollars (unaudited)

 

 

13.SHARE CAPITAL (CONT’D)

 

As at March 31, 2025, the Company had the following RSUs outstanding:

 

   Number of RSUs 
Outstanding, December 31, 2023   44,545 
Vested   (25,353)
Issued   185,240 
Forfeited   (16,332)
Outstanding, December 31, 2024   188,100 
Vested   (16,998)
Forfeited   (1,001)
Outstanding, March 31, 2025   170,101 

 

Warrants

 

During the year ended December 31, 2024 and the year ended December 31, 2023, the Company issued pre-funded warrants (“USD pre-funded Warrants”) where a portion of the funds related to the eventual exercise have already been received with the remaining exercise price in USD. As part of these same issuances, shares with warrants attached were issued. Being in a foreign currency that is not the Company’s functional currency and these pre-funded warrants were not issued in exchange for services, the value related to the future exercise price of the USD pre-funded Warrants are required to be recorded as a financial liability and not as equity. As a financial liability, the portion of the USD pre-funded Warrants related to the future exercise price will be revalued on a quarterly basis to fair market value with the change in fair value being recorded in profit or loss. The warrants issued with the shares are also in USD so are also accounted for as a liability. In addition, the Company also issued pre-funded warrants with an exercise price in Canadian dollars (“Pre-funded Warrants”). These are also treated as a liability as the agreement contains clauses that do not meet the fixed for fixed test. As a financial liability, the portion of the Pre-funded Warrants related to the future exercise price will be revalued on a quarterly basis to fair market value with the change in fair value being recorded in profit or loss. The warrants issued with the shares are also accounted for as a liability as these also contain clauses that do not meet the fixed for fixed test.

 

On August 7, 2024, the exercise price of the April 29, 2024 warrants were amended to CAD $0.2250 or CAD $5.625 on a post share consolidation basis. The exercise price of the October Warrants was reduced twice and converted to Canadian dollars for a new exercise price of CAD $5.6925. For the October 2023 issuance and the April 2024 issuance, the warrant agreements were further amended as of August 7, 2024 to remove the cashless exercise feature and any anti-dilution clauses that would lead to variability in settlement so they now meet the requirement for equity classification. The warrants were fair valued on August 7, 2024 and transferred to equity.

 

On November 19, 2024 the exercise prices of the April 2024 warrants and the October 2023 warrants were amended to CAD$3.3086 from CAD$5.625 and CAD$5.6925 respectively.

 

No warrants were issued during the three months ended March 31, 2025.

 

To determine the a fair value of the warrants, a Black Scholes calculation is used, calculated in USD for those with a USD exercise price and in CAD for those with a Canadian exercise price. The Black Scholes value per warrant is then multiplied by the number of outstanding warrants and then multiplied by the foreign exchange rate at the end of the period for those denominated in USD.

 

 

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2025

Expressed in Canadian Dollars (unaudited)

 

 

13.SHARE CAPITAL (CONT’D)

 

   February Issuance   April Issuance   August Issuance   November Issuance 
   Warrants   Broker   Warrants   Broker   Broker   Broker 
Volatility   119.23%   107.8%   119.80%   108.67%   118.87%   115.27%
Risk free rate   4.33%   4.48%   4.65%   4.62%   3.74%   4.24%
Expected life   5 years    3 years    5 years    3 years    3 years    3 years 
Expected dividend yield   0%   0%   0%   0%   0%   0%

 

Warrant Derivative Liability

 

Balance at December 31, 2023  $4,196,125 
Warrants issued   7,282,325 
Exercised   (3,661,283)
Change in fair value of warrants outstanding   (1,842,618)
Reclassify to equity   (3,776,428)
Balance at December 31, 2024  $2,198,121 
Change in fair value of warrants outstanding   (157,830)
Balance at March 31, 2025  $2,040,291 

 

Details of liability warrants and their fair values are as follows:

 

Issue Date  Exercise Price  

Number of Warrants Outstanding at

March 31, 2025

  

Fair Value at

March 31, 2025

  

Number of Warrants Outstanding at

December 31, 2024

  

Fair Value at

December 31, 2024

 
Derivative Liability                    
February 26, 2024 (1)  US$4.4025    474,332    $2,040,291    474,332   $2,198,121 
         474,332   $2,040,291    474,332   $2,198,121 

 

1)The warrants expire February 26, 2029.

 

Warrants

 

   Exercise Price    Number of Warrants Outstanding at March 31, 2025   Number of Warrants Outstanding at December 31, 2024 
October 30, 2023 (1)  $ 3.3086     256,000    256,000 
April 29, 2024 (2)  $ 3.3086     540,541    540,541 
August 21, 2024 (3)  $ 5.12     666,667    666,667 
November 19, 2024 (4)  $ 3.3086     1,600,000    1,600,000 
           3,063,208    3,063,208 

 

1)The warrants expire October 30, 2028. These were moved from derivative liability August 7, 2024.
2)The warrants expire April 29, 2029. These were moved from derivative liability August 7, 2024.
3)The warrants expire August 21, 2029.
4)The warrants expire November 19, 2029

 

The fair values of these warrants were estimated using the Black-Scholes Option Pricing Model with the following weighted average assumptions:

 

   March 31, 2025   December 31, 2024 
Risk free interest rate   3.96%   4.38%
Expected volatility   117.34%   124.06%
Expected life   3.91 years    4.16 years 
Expected dividend yield   0%   0%

 

 

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2025

Expressed in Canadian Dollars (unaudited)

 

 

13.SHARE CAPITAL (CONT’D)

 

   Number of Warrants   Weighted Average Exercise Price 
Outstanding, December 31, 2023   342,992   $15.75 
Issued   5,376,370    3.35 
Exercised   (1,991,668)   0.9596 
Expired   (10,192)   125.00 
Outstanding, December 31, 2024 and March 31, 2025   3,717,502   $5.16 

 

As at March 31, 2025, the Company had the following warrants outstanding:

   

Date issued  Expiry date  Exercise price  Number of warrants outstanding 
October 30, 2023  October 30, 2026  CAD$ 23.20   12,800 
October 30, 2023  October 30, 2028  CAD$ 3.3086   256,000 
February 26, 2024  February 26, 2027  US$ 8.44   26,800 
February 26, 2024  February 26, 2029  US$ 4.4025   474,332 
April 29, 2024  April 29, 2029  CAD$ 3.3086   540,541 
April 29, 2024  April 29, 2024  CAD$ 11.06   27,028 
August 21, 2024  August 21, 2027  CAD$ 5.12   33,334 
August 21, 2024  August 21, 2029  CAD$ 5.12   666,667 
November 19, 2024  November 19, 2029  CAD$ 3.3086   1,600,000 
November 19, 2024  November 19, 2027  CAD$ 4.1357   80,000 
            3,717,502 

 

The weighted average remaining contractual life of warrants outstanding as of March 31, 2025, was 4.25 years (December 31, 2024 – 4.5 years).

 

14.SEGMENTED INFORMATION

 

As at and for the three months ended March 31, 2025 the Company operates in 2 reportable segments (as at and for the year ended December 21, 2024 – 2). The Company organizes its two segments based on its product line as well as a corporate segment. The two segments are Drones and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV) while the Corporate segment includes all costs not directly associated with the Drone segment. The Company aggregates the information for the segments by analyzing the revenue stream and allocating direct costs to that respective segment. The Corporate segment is aggregated by relying on the entity that includes corporate costs (Draganfly Inc.).

 

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision maker.

 

 

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2025

Expressed in Canadian Dollars (unaudited)

 

 

14.SEGMENTED INFORMATION (CONT’D)

 

The board of the Company relies on executive management which assesses the financial performance and position of the group and makes strategic decisions. Executive management, which has been identified as being the chief operating decision maker, consists of the chief executive officer, chief operating officer and chief financial officer.

 

March 31, 2025  Drones   Corporate   Total 
Sales of goods  $1,541,811   $-   $1,541,811 
Provision of services   5,904    -    5,904 
Total revenue   1,547,715    -    1,547,715 
Segment loss (income)   1,872,918    1,295,088    3,168,006 
Finance and other costs   34,031    -    34,031 
Depreciation   72,221    3,195    75,416 
Amortization   2,257    -    2,257 
Change in fair value of derivative liability   -    157,830    157,830 
Loss on write-off of notes receivable   -    25,951    25,951 
Recovery of write down of inventory (note 5)   (38,666)   -    (38,666)
Net loss for the period  $1,942,761   $1,482,064   $3,424,825 

 

March 31, 2024  Drones   Corporate   Total 
Sales of goods  $1,237,948   $-   $1,237,948 
Provision of services   91,633    -    91,633 
Total revenue   1,329,581    -    1,329,581 
Segment loss   1,240,820    (1,500,860)   (260,040)
Finance and other costs   4,825   -    4,825
Depreciation   139,109    4,013    143,122 
Amortization   2,821    -    2,821 
Change in fair value of derivative liability   -    1,817,569    1,817,569 
Loss on write-off of notes receivable   -    6,751    6,751 
Loss on write down of inventory (note 5)   148,760    -    148,760 
Net loss for the period  $1,536,335   $327,473   $1,863,808 

 

Geographic revenue is measured by aggregating sales based on the country and the entity where the sale was made.

 

 

   March 31, 2025   December 31, 2024 
Non-current assets          
Canada  $1,067,472   $1,117,513 
   $1,067,472   $1,117,513 

 

       
   For the three months ended March 31, 
   2025   2024 
Revenue          
Canada  $1,544,083   $1,327,333 
United States   3,632    2,248 
Revenue   $1,547,715   $1,329,581 

 

 

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2025

Expressed in Canadian Dollars (unaudited)

 

 

15.OFFICE AND MISCELLANEOUS

 

   2025   2024 
   For the three months ended March 31, 
   2025   2024 
Advertising, Marketing, and Investor Relations  $223,984   $110,073 
Compliance fees   35,783    64,031 
Other   277,922    172,166 
Office and Miscellaneous Expenses  $537,689   $346,270 

 

16.OTHER EXPENSE

 

   2025   2024 
   For the three months ended March 31, 
   2025   2024 
Share issue costs  $-   $(598,529)
Write off of accounts (payable) receivable   (24,473)   48,833
Other   23    (2,599)
Total other expenses  $(24,450)  $(552,295) 

 

17.RELATED PARTY TRANSACTIONS

 

On August 1, 2019, the Company entered in a business services agreement (the “Agreement”) with Business Instincts Group (“BIG”), a company that Cameron Chell, CEO and director has a material interest in that he previously controlled, to provide: corporate development and governance, strategic facilitation and management, general business services, office space, corporate business development video content, website redesign and management, and online visibility management. The services are provided by a team of consultants and the costs of all charges are based on the fees set in the Agreement. For the three months ended March 31, 2025, the Company incurred fees of $93,283 (2024 - $60,000). As at March 31, 2025, the Company was indebted to this company in the amount of $9,524 (2024 - $nil).

 

On October 1, 2019, the Company entered into an independent consultant agreement (“Consultant Agreement”) with 1502372 Alberta Ltd, a company controlled by Cameron Chell, CEO and director, to provide executive consulting services to the Company. The costs of all charges are based on the fees set in the Consultant Agreement. For the three months ended March 31, 2025, the Company incurred fees of $104,226 (2024 - $106,250). As at March 31, 2025, the Company was indebted to this company in the amount of $nil (2024 - $nil).

 

On July 3, 2020, the Company entered into an executive consultant agreement (“Executive Agreement”) with Scott Larson, a director of the Company, to provide executive consulting services, as President, to the Company. On May 9, 2022, Scott Larson ceased to be President of the Company and entered into an agreement to provide executive consulting services to the Company and all fees are set in the consulting agreement. For the three months ended March 31, 2025, the Company incurred fees of $2,861 (2024 - $40,433). As at March 31, 2025, the Company was indebted to this company in the amount of $13,300 (2024 - $nil).

 

Trade receivables/payables and accrued receivables/payables:

 

As at March 31, 2025, the Company had $155,475 (2024 - $298,100) payable to related parties that was included in accounts payable. The balances outstanding are unsecured, non-interest bearing and due on demand.

 

Key management compensation

 

Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. Compensation awarded to key management for the three months ended March 31, 2025 and 2024 included:

 

   2025   2024 
   For the three months ended March 31, 
   2025   2024 
Director fees  $132,651   $152,438 
Salaries   217,510    142,068 
Share-based payments   194,200    122,112 
Total  $544,361   $416,618 

 

Other related party transactions

 

   2024   2024 
   For the three months ended March 31, 
   2025   2024 
Management fees paid to a company controlled by CEO and director  $104,226   $106,250 
Management fees paid to a company that the CEO holds an economic interest in   93,283    60,000 
Management fees paid to a company controlled by the former President and director   2,861    40,433 
Management fees paid to a company, total   $200,370   $206,683 

 

 

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2025

Expressed in Canadian Dollars (unaudited)

 

 

18.FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT

 

The Company is exposed in varying degrees to a variety of financial instrument related risks. The Board of Directors approves and monitors the risk management processes, inclusive of documented investment policies, counterparty limits, and controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows:

 

Credit risk

 

Credit risk is the risk that of an unexpected loss if a customer or third party fails to meet its contractual obligations.

 

The Company is subject to credit risk on its cash and receivables. The majority of cash is deposited in bank accounts held with a major bank in Canada and the United States. As most of the Company’s cash is held by one bank there is a concentration of credit risk. This risk is managed by using major banks that are high credit quality financial institutions as determined by rating agencies.

 

Receivables

 

Receivables primarily consist of trade receivables and taxes receivable. The Company provides credit in the normal course of business in the form of payment terms and has an established process for determining terms to offer customers to mitigate credit risk. Receivables are shown net of any provision made for impairment of the receivables. Due to this factor, the Company believes that no additional credit risk, beyond amounts provided for collection loss, is inherent in receivables.

 

Expected credit loss (“ECL”) analysis is performed at each reporting date using an objective approach to measure expected credit losses. The provision amounts are based on direct management interface with the customer. The calculations reflect the probability-weighted outcome, the time value of money and reasonable supportable information that is available at the reporting date about past events, current conditions and forecasts of future economic conditions. Receivables are written off where there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, amongst others, business failure, the failure of a debtor to engage in a repayment plan, and a failure to make contractual payments over the negotiated contract period.

 

Fair value

 

A number of the Company’s accounting policies and disclosures require the measurement of fair values for financial assets and liabilities. The Company has established a control framework with respect to the measurement of fair values. Fair values are categorized into different levels of a fair value hierarchy based on the inputs used in the valuation techniques as follows:

 

Level 1: quoted (unadjusted) prices in active markets for identical assets or liabilities.

Level 2: other techniques for which all inputs which have a significant effect on the recorded fair value are observable, either directly or indirectly.

Level 3: techniques which use inputs which have a significant effect on the recorded fair value that are not based on observable market data.

 

Equity securities in investee companies and warrants are measured at fair value. The financial assets and liabilities measured at fair value by hierarchy are shown in the table below. The amounts shown are based on the amounts recognized in the condensed consolidated interim statements of financial position. These financial assets are measured at fair value through profit and loss.

 

 

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2025

Expressed in Canadian Dollars (unaudited)

 

 

18.FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT’D)

 

March 31, 2025  Level 1   Level 3   Total 
Equity securities in investee companies  $21,459   $-   $21,459 
Derivative liability   -    (2,040,291)   (2,040,291)
Total  $21,459   $(2,040,291)  $(2,018,832)

 

December 31, 2024  Level 1   Level 3   Total 
Equity securities in investee companies  $14,286   $-   $14,286 
Derivative liability   -    (2,198,121)   (2,198,121)
Total  $14,286   $(2,198,121)  $(2,183,835)

 

The following table shows the valuation techniques used in measuring Level 3 fair values for the derivative liability as well as the significant unobservable inputs used.

 

 

Type

 

 

Valuation technique

 

 

Key inputs

 

Inter-relationship between significant

inputs and fair value measurement

Warrant derivative liability   The fair value of the warrants derivative liability at initial recognition and at year end has been calculated using the Black Scholes Option Pricing Model  

Key observable inputs

●  Share price

●  Risk free interest rate

●  Dividend yield

Key unobservable inputs

●  Expected volatility

 

The estimated fair value would increase (decrease) if:

●  The price was higher (lower)

●  The risk-free rate was higher (lower)

●  The dividend yield was lower (higher)

●  The expected volatility was higher (lower)

 

For the fair value of the derivative liability, reasonable possible changes to the expected volatility, the most significant unobservable input would have the following effects:

 

Unobservable Inputs  Change   Impact on comprehensive loss 
      

Three months ended

March 31, 2025

  

Year ended

December 31, 2024

 
Volatility   20%  $29,994   $201,109 

 

19.SUBSEQUENT EVENT

 

On May 5, 2025, The Company closed a financing for 1,715,000 units of the Company, with each unit consisting of one common share and one warrant to purchase one common share. Each unit was sold at an offering price of $2.10 for gross proceeds of approximately US$ 3.6 million before deducting underwriting discounts and offering expenses. Estimated costs related to the issuance are CAD$ 581,000.